Document Actions
BioPredictive celebrates 300,000 tests
From clinical innovation to routine usage, BioPredictive has revolutionized the diagnosis of hepatic fibrosis by offering tests that are noninvasive, quick and low-cost.
FibroTest was born in 2001 and since the launch of the website in September 2002, a very large number of you have placed your trust in us, since 300,000 FibroTests have already been performed!
These 5 years of FibroTest utilisation and the analysis of the first 300,000 tests have enabled us to determine the following distribution of liver fibrosis :
 |
31% of patients with severe fibrosis stages F3 or F4, in the “red zone”, including 17% with cirrhosis (stage F4) |
 |
26% of patients presenting with intermediary lesions stages F1-F2, in the “orange zone”. |
 |
43% of patients with no or minimal fibrosis stages F0, F1, in the “green zone” |
